Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-028881
Filing Date
2024-04-01
Accepted
2024-04-01 17:11:53
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0202691-s3_immucell.htm S-3 299814
2 OPINION OF LOEB & LOEB LLP ea020269101ex5-1_immucell.htm EX-5.1 26427
3 CONSENT OF WIPFLI LLP ea020269101ex23-2_immucell.htm EX-23.2 1828
4 FILING FEE TABLE ea020269101ex-fee_immucell.htm EX-FILING FEES 35076
5 GRAPHIC ex5-1_001.jpg GRAPHIC 3407
6 GRAPHIC ex5-1_002.jpg GRAPHIC 1578
  Complete submission text file 0001213900-24-028881.txt   371271
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278438 | Film No.: 24810826
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)